揭示TIM-3基因多态化在全源造血干细胞移植中的潜力 - 一项初步研究
Sylwia Biały1, Jagoda Siemaszko1, Małgorzata Sobczyk-Kruszelnicka2
1Laboratory of Clinical Immunogenetics and Pharmacogenetics, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland.
Transplant immunology
|July 11, 2024
概括
在T细胞免疫球蛋白和含有-3 (TIM-3) 的粘素域中的遗传变异可以影响血造干细胞移植 (HSCT) 的结果. 特定的TIM-3多态可能会降低急性移植对宿主疾病的风险,并影响移植后的细胞巨乳病毒感染率.
科学领域:
- 免疫学 免疫学 免疫学
- 移植医学 移植医学
- 遗传学 是一个遗传学.
背景情况:
- 含有T细胞免疫球蛋白和粘素域-3 (TIM-3) 是一个关键的免疫反应调节器.
- 了解TIM-3在造血干细胞移植 (HSCT) 中的作用对于改善结果至关重要.
- 本研究研究了TIM-3基因多态性 (rs1036199和rs10515746) 以及它们与HSCT后结果的关联.
研究的目的:
- 评估TIM-3多态度 (rs1036199和rs10515746) 与异构HSCT结果之间的关联.
- 确定TIM-3遗传变异是否会影响急性移植对宿主疾病 (aGvHD) 和细胞巨乳病毒 (CMV) 感染的风险.
- 探索捐赠者-接受者TIM-3基因匹配在优化HSCT策略中的潜力.
主要方法:
- 在120名全基性HSCT患者及其捐赠者中,TIM-3单核酸多态 (SNP) rs1036199和rs10515746的基因定型.
- 实时PCR与TaqMan测定被用于SNP基因型鉴定.
- 进行多变量分析以确认影响结果的独立因素.
主要成果:
- 对rs1036199和rs10515746具有罕见等位基因或异合体基因型的接受者,急性移植对宿主疾病 (aGvHD) 的发生频率降低.
- rs10515746多态性,特别是衰退的A等位基因,与aGvHD无生存率有关.
- 细胞巨乳病毒 (CMV) 感染在不匹配的TIM-3 rs10515746捐赠者患者中更频繁,独立于HLA和CMV-IgG状态.
- 多变量分析确定了TIM-3不相容性和衰退性等位基因作为aGvHD和CMV的独立风险因素.
结论:
- TIM-3基因多态性可以影响HSCT接受者的免疫反应.
- rs1036199和rs10515746SNP的衰退性等位基因与aGvHD风险降低有关.
- 捐赠者-接受者TIM-3基因匹配可能在减轻移植后CMV感染风险方面发挥作用,这表明HSCT优化基因分析的价值.
相关概念视频
Bone Marrow Sampling and Transplants
323
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
323
Tissue Transplantation
354
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
354
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K


